Loading…
Polaryx Therapeutics, Inc. is projected to decline to $2.14 by 2027, a -15% move from its current price of $2.51. PLYX is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $2.25 | $2.51 | $2.80 | -0.08% |
| May 30 | $2.15 | $2.51 | $2.92 | -0.15% |
| May 31 | $2.07 | $2.50 | $3.02 | -0.23% |
| Jun 1 | $2.01 | $2.50 | $3.11 | -0.31% |
| Jun 2 | $1.96 | $2.50 | $3.19 | -0.39% |
| Jun 3 | $1.91 | $2.50 | $3.26 | -0.46% |
| Jun 4 | $1.87 | $2.50 | $3.33 | -0.54% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.87 | $2.50 | $3.33 | -0.54% |
| Week 2 | $1.65 | $2.48 | $3.73 | -1.08% |
| Week 3 | $1.50 | $2.47 | $4.07 | -1.61% |
| Week 4 | $1.38 | $2.46 | $4.37 | -2.14% |
| Week 5 | $1.28 | $2.44 | $4.65 | -2.67% |
| Week 6 | $1.20 | $2.43 | $4.92 | -3.20% |
| Week 7 | $1.13 | $2.42 | $5.18 | -3.72% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Polaryx Therapeutics, Inc. is a clinical-stage biotechnology company that engages in the discovery, development, and commercialization of disease-modifying therapies for rare and pediatric lysosomal storage disorders in the United States. Its pipeline includes PLX-100, a preclinical stage orally administrable combination therapy; PLX-200, a repurposed oral small molecule for the treatment of LSDs; PLX-300, a preclinical stage orally administrable combination therapy; and PLX-400, a preclinical stage novel gene therapy candidate.
The company was founded in 2014 and is based in Paramus, New Jersey. It operates in the Healthcare sector.
Polaryx Therapeutics, Inc. trades under the ticker symbol PLYX. The current price is $2.51 and the company has a market capitalization of $118.83M, with a ranking of 4102.
A major floor 4.0% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.0% away) — a key level to hold.
The nearest ceiling, 157.4% above — a clean break opens room to run.
A major ceiling 1294.4% above — clearing it would confirm fresh momentum.
Key PLYX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of PLYX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $3.20 | Sell | $2.96 | Sell |
| MA 10 | $3.13 | Sell | $3.20 | Sell |
| MA 20 | $3.71 | Sell | $3.69 | Sell |
| MA 50 | $5.10 | Sell | $5.76 | Sell |
| MA 100 | — | Neutral | — | Neutral |
| MA 200 | — | Neutral | — | Neutral |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 33.01 | Neutral |
| Stoch RSI (14) | 38.34 | Neutral |
| CCI (20) | -116.57 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | -31.42 | Sell |
| Bollinger %B (20,2) | 0.15 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -1.96 | Sell |
| Awesome (5,34) | -1.35 | Sell |
| Ultimate (7,14,28) | 40.86 | Neutral |
| Momentum (10) | -0.77 | Sell |
| Aroon Osc (25) | -80.00 | Sell |
| Hull MA (9) | 3.09 | Sell |
| ADX (14) | 31.83 | Sell |
| ATR (14) | 0.38 | Info |
The 30-day technical picture is NEUTRAL. The RSI(14) is 30, and the 50-day simple moving average is $5.10. The current support level is $2.51 and the resistance is $6.46. The 30-day price range runs from $1.23 to $5.14, indicating a broad, volatile trading window. Annualized volatility is 200%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.41 | $2.51 | $3.82 | 0% | Neutral | |
| $1.38 | $2.14 | $3.59 | -15% | Neutral | |
| $1.04 | $1.78 | $3.24 | -29% | Bearish | |
| $1.09 | $2.05 | $3.97 | -18% | Bearish | |
| $1.00 | $2.05 | $4.18 | -18% | Bearish | |
| $1.20 | $2.68 | $5.69 | +7% | Neutral | |
| $1.35 | $3.00 | $6.63 | +20% | Neutral | |
| $1.17 | $2.59 | $5.92 | +3% | Neutral | |
| $1.24 | $2.75 | $6.33 | +10% | Neutral | |
| $1.14 | $2.54 | $5.84 | +1% | Neutral | |
| $1.63 | $3.62 | $8.34 | +44% | Bullish | |
| $2.93 | $6.50 | $14.95 | +159% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $2.41 | $2.51 | $3.01 | +0.00% |
| June 2026 | $1.94 | $2.38 | $3.06 | -5.05% |
| July 2026 | $1.86 | $2.34 | $3.12 | -1.86% |
| August 2026 | $1.93 | $2.48 | $3.39 | +5.91% |
| September 2026 | $1.91 | $2.50 | $3.50 | +0.95% |
| October 2026 | $1.82 | $2.42 | $3.45 | -3.27% |
| November 2026 | $1.85 | $2.49 | $3.62 | +3.10% |
| December 2026 | $1.90 | $2.59 | $3.82 | +3.84% |
Click any year to see its month-by-month PLYX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect PLYX to range from $2.41 to $3.82 through 2026. The $2.51 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The PLYX price prediction for 2027 points to an average of $2.14 (low $1.38, high $3.59) — a potential decline of -15% on today's $2.51. A consolidation phase looks the most probable path here.
In 2028, PLYX is projected to trade between $1.04 and $3.24, averaging $1.78 — a potential decline of -29% from today's $2.51. That is -17% versus the projected 2027 average. A cyclical pullback looks likely — prices rarely move in a straight line.
Polaryx Therapeutics, Inc.'s 2029 outlook centres on $2.05, within a $1.09 to $3.97 range. That is up +15% on the projected 2028 average. That marks a -18% change versus current levels. Expect choppier, lower action through this leg of the cycle.
By 2030, PLYX could reach as high as $4.18, with a base case around $2.05 and support toward $1.00 — roughly -18% from $2.51. A cyclical pullback looks likely — prices rarely move in a straight line.
Expect PLYX to range from $1.20 to $5.69 through 2031. The $2.68 average target implies a +7% move from current prices. That is up +30% on the projected 2030 average. A consolidation phase looks the most probable path here.
The PLYX price prediction for 2032 points to an average of $3.00 (low $1.35, high $6.63) — a potential gain of +20% on today's $2.51. Price action looks broadly range-bound.
In 2033, PLYX is projected to trade between $1.17 and $5.92, averaging $2.59 — a potential gain of +3% from today's $2.51. That is -14% versus the projected 2032 average. A consolidation phase looks the most probable path here.
Polaryx Therapeutics, Inc.'s 2034 outlook centres on $2.75, within a $1.24 to $6.33 range. That is up +6% on the projected 2033 average. That marks a +10% change versus current levels. Price action looks broadly range-bound.
By 2035, PLYX could reach as high as $5.84, with a base case around $2.54 and support toward $1.14 — roughly +1% from $2.51. A consolidation phase looks the most probable path here.
Expect PLYX to range from $1.63 to $8.34 through 2040. The $3.62 average target implies a +44% move from current prices. That is up +43% on the projected 2035 average. Momentum favours further upside here.
The PLYX price prediction for 2050 points to an average of $6.50 (low $2.93, high $14.95) — a potential gain of +159% on today's $2.51. Buyers look set to stay in control over this stretch.
Investing $1,000 in PLYX today (≈ 398.406375 PLYX) could be worth
$2,590.05
+$1,590.05 (+159%) by 2050 · US Dollar
Based on the average projected PLYX price of $6.5 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in PLYXwould be worth at today's price.
$1,000 invested in PLYX on Feb 2, 2026 (≈ 28.571429 PLYX) would be worth
$71.71
-$928.29 (-92.8%) today · 0.07× · US Dollar
Based on a PLYX entry price of $35 vs. today's $2.51.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $3.38 | $742.6 | -25.7% |
| 1 month ago | $5.07 | $495.07 | -50.5% |
| 3 months ago | $3.19 | $786.83 | -21.3% |
| All time ago | $35 | $71.71 | -92.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our PLYX forecast.
Our base-case forecast reaches $5.00 around 2050.
Implied market cap at $5.00: $236.72M
The year-by-year forecast shows a mixed multi-year path. In 2026 the avg is $2.51 with a $0 ROI and NEUTRAL sentiment; 2027 shows an avg of $2.14 with -14.8% ROI and NEUTRAL sentiment; 2028 projects an avg of $1.78 with -29.1% ROI and BEARISH sentiment; 2029, avg $2.05 with -18.2% ROI and BEARISH sentiment; 2030, avg $2.05 with -18.2% ROI and BEARISH sentiment. The forecast then turns toward stronger values in later years, with 2031 avg $2.68 (6.7% ROI, NEUTRAL), 2032 avg $3.00 (19.6% ROI, NEUTRAL), 2033 avg $2.59 (3.2% ROI, NEUTRAL), 2034 avg $2.75 (9.7% ROI, NEUTRAL), and 2035 avg $2.54 (1.1% ROI, NEUTRAL).
The outlook becomes bullish in 2040 (avg $3.62, ROI 44.4%) and again in 2050 (avg $6.50, ROI 159%). The 2040 and 2050 sentiments are listed as BULLISH.
Tap a question to reveal the answer.
2030 has an avg of $2.05 with a max of $4.18 and a min of $1.00, corresponding to a -18.2% ROI and BEARISH sentiment.
Forecasts show a mixed path: NEUTRAL in 2026, turning BEARISH in 2027–2030, then NEUTRAL again through 2035, with BULLISH prospects in 2040 and 2050. The 2040 avg is $3.62 (ROI 44.4%), and the 2050 avg is $6.50 (ROI 159%), but there are periods of lower averages and negative returns in the near term.
Yes. The forecast maximum in 2050 is $14.95, which indicates that reaching $10 is within the projected range by that year.
The current price is $2.51 and the market cap is $118.83M.
The sentiment is NEUTRAL with RSI(14) at 30. The 50-day SMA is $5.10. Support is at $2.51 and resistance at $6.46. The 30-day range is $1.23 to $5.14, and annualized volatility is 200%.
Polaryx Therapeutics, Inc. Community Discussion
0Share your Polaryx Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.